- Home
- WALD vs IMRX Comparison
WALD vs IMRX Comparison
Compare WALD & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WALD
- IMRX
- Stock Information
- Founded
- WALD 1988
- IMRX 2008
- Country
- WALD United States
- IMRX United States
- Employees
- WALD N/A
- IMRX N/A
- Industry
- WALD Package Goods/Cosmetics
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- WALD Consumer Discretionary
- IMRX Health Care
- Exchange
- WALD Nasdaq
- IMRX Nasdaq
- Market Cap
- WALD 228.8M
- IMRX 232.9M
- IPO Year
- WALD 2021
- IMRX 2021
- Fundamental
- Price
- WALD $2.51
- IMRX $7.66
- Analyst Decision
- WALD Strong Buy
- IMRX Strong Buy
- Analyst Count
- WALD 5
- IMRX 5
- Target Price
- WALD $4.76
- IMRX $17.20
- AVG Volume (30 Days)
- WALD 140.5K
- IMRX 1.2M
- Earning Date
- WALD 11-24-2025
- IMRX 11-12-2025
- Dividend Yield
- WALD N/A
- IMRX N/A
- EPS Growth
- WALD N/A
- IMRX N/A
- EPS
- WALD N/A
- IMRX N/A
- Revenue
- WALD $274,560,000.00
- IMRX N/A
- Revenue This Year
- WALD $10.37
- IMRX N/A
- Revenue Next Year
- WALD $14.37
- IMRX N/A
- P/E Ratio
- WALD N/A
- IMRX N/A
- Revenue Growth
- WALD 14.22
- IMRX N/A
- 52 Week Low
- WALD $1.48
- IMRX $1.10
- 52 Week High
- WALD $4.18
- IMRX $10.08
- Technical
- Relative Strength Index (RSI)
- WALD 61.15
- IMRX 65.04
- Support Level
- WALD $2.18
- IMRX $6.62
- Resistance Level
- WALD $3.21
- IMRX $7.62
- Average True Range (ATR)
- WALD 0.36
- IMRX 0.56
- MACD
- WALD 0.07
- IMRX 0.08
- Stochastic Oscillator
- WALD 56.41
- IMRX 94.60
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.